Tanshinone IIA exerts antitumor activity against vestibular schwannoma cells by inhibiting the expression of hypoxia-inducible factor-1 alpha
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ju Yeon | - |
dc.contributor.author | Song, Jae-Jun | - |
dc.contributor.author | Kwon, Byoung-Mog | - |
dc.contributor.author | Lee, Jong Dae | - |
dc.date.accessioned | 2021-08-11T19:44:59Z | - |
dc.date.available | 2021-08-11T19:44:59Z | - |
dc.date.issued | 2015-09 | - |
dc.identifier.issn | 1791-2997 | - |
dc.identifier.issn | 1791-3004 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10342 | - |
dc.description.abstract | The aim of the present study was to evaluate the effect of the herbal medicine, tanshinone IIA (Tan IIA), on vestibular schwannoma (VS) cells and assess the functional targets of Tan IIA. HEI-193 cells and Nf2-/-mouse Schwann (SC4) cells were used to investigate the inhibitory effects of Tan IIA on VS. Cell viability was measured using an MTT assay and apoptosis was assessed by flow cytometry. Western blot analysis and reverse transcription quantitative polymerase chain reaction (RT-qPCR) were performed to assess the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and its signaling pathways. In addition, the effect of Tan IIA on HIF-1a transcription was determined using a luciferase reporter assay. Schwannoma cell proliferation was observed to be inhibited as the Tan IIA concentration increased under normoxic and hypoxic conditions. Furthermore, Tan IIA induced apoptosis in the HEI-193 cells and inhibited the protein expression of HIF-1 alpha in the HEI-193 cells under hypoxia, thus repressing the transcriptional activity of HIF-1 alpha. The present study demonstrated that HIF-1 alpha is expressed in hypoxic VS cells and Tan IIA inhibits VS cells by suppressing the activity of HIF-1 alpha. In conclusion, these results indicate that Tan IIA is a potential chemotherapeutic agent for the treatment of VS. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Spandidos Publications | - |
dc.title | Tanshinone IIA exerts antitumor activity against vestibular schwannoma cells by inhibiting the expression of hypoxia-inducible factor-1 alpha | - |
dc.type | Article | - |
dc.publisher.location | 그리이스 | - |
dc.identifier.doi | 10.3892/mmr.2015.3932 | - |
dc.identifier.scopusid | 2-s2.0-84935454896 | - |
dc.identifier.wosid | 000359933900195 | - |
dc.identifier.bibliographicCitation | Molecular Medicine Reports, v.12, no.3, pp 4604 - 4609 | - |
dc.citation.title | Molecular Medicine Reports | - |
dc.citation.volume | 12 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 4604 | - |
dc.citation.endPage | 4609 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | FACTOR-I | - |
dc.subject.keywordPlus | APOPTOSIS INDUCTION | - |
dc.subject.keywordPlus | GROWTH-INHIBITION | - |
dc.subject.keywordPlus | CANCER-THERAPY | - |
dc.subject.keywordPlus | FACTOR 1-ALPHA | - |
dc.subject.keywordPlus | HIF-1 | - |
dc.subject.keywordPlus | THERAPEUTICS | - |
dc.subject.keywordPlus | VITRO | - |
dc.subject.keywordAuthor | vestibular schwannoma | - |
dc.subject.keywordAuthor | hypoxia-inducible factor | - |
dc.subject.keywordAuthor | tanshinone IIA | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.